Chaperone, Heat shock protein (Hsp70 family), Mitochondrial protein, Other
01
Overview
Heat shock protein family A member 9 (HSPA9), also known as mortalin or GRP75, is a mitochondrial chaperone protein belonging to the Hsp70 family. Predominantly localized in mitochondria but also present in the endoplasmic reticulum, cytosol, plasma membrane, nucleus, and extracellularly, HSPA9 is essential for mitochondrial protein import, proper protein folding, and quality control. It also contributes to the biogenesis of mitochondrial iron-sulfur clusters, modulates apoptosis (by interacting with calcium channels and apoptosis regulators), and protects against oxidative and proteotoxic stress. HSPA9 plays key roles in cell proliferation, differentiation, and senescence, and its dysfunction is linked to cancer, aging, genetic syndromes, and neurodegeneration. Overexpression and abnormal localization of HSPA9 are frequently observed in tumors, suggesting it as a potential therapeutic target, though with notable challenges due to its vital cellular functions.
Other names
GRP75PBP7475 kDa glucose-regulated proteinStress-70 protein, mitochondrialmt-HSP70HSPA9BMortalinMortalin2Mot-2Mthsp75Peptide-binding protein 74MOTEpididymis secretory sperm binding protein Li 124mHeat shock 70 kDa protein 9Mitochondrial Hsp70
02
Mechanism of action
Inhibition of chaperone function leads to proteotoxic stress, mitochondrial dysfunction, and selective tumor cell death. Modulation of mitochondrial import/function, proliferation, and cell survival pathways.
03
Biological functions
Mitochondrial protein import and foldingProtein quality control (chaperone-mediated folding, prevention of aggregation)Iron-sulfur cluster biogenesisRegulation of apoptosisRegulation of cell proliferation and cell cycleCellular stress response (including oxidative and proteotoxic stress)Cellular agingCalcium homeostasis
04
Disease associations
Cancer (tumorigenesis, found upregulated and mislocalized in tumors, facilitates survival and proliferation)Neurodegenerative diseases (implicated in axonal and neuronal protection, Parkin/PINK1 axis)Even-plus syndrome (genetic deficiency causes congenital malformations)Anemia, sideroblastic, 4AgingOther mitochondrial disorders
05
Safety considerations
Mitochondrial toxicity and impairment of essential housekeeping functions (risk of off-target effects, particularly in non-cancer cells)Potential impairment of normal cell survival and stress responsesPossible induction of anemia, neurodegenerative symptoms, or accelerated aging if inhibited systemically
06
Interacting drugs
None definitively approved for clinical use; pilot inhibitors and siRNA are being researched in cancer and neurodegeneration.
1 more in the full profile.
07
Biomarkers
Overexpression or mislocalization of HSPA9/mortalin as a biomarker of poor prognosis in several cancersReduced mortalin levels in neurodegenerative disease brainsMutational analysis for Even-plus syndrome
Beyond the preview
Go deeper on Heat shock protein family A member 9 (HSPA9).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Heat shock protein family A member 9 (HSPA9).